Currently, diagnosis of LTBI involves assessment of the reactivity to mycobacterial antigens, as determined by a tuberculin skin test (TST) or an M. tuberculosis (MTB)-specific interferon-gamma (IFN-γ) release assay (IGRA), which can demonstrate the elicitation of a T cell-mediated immune response caused by the infection. The gene discussed is IFNG; the disease is infection.